Melanoma Treatment in Azerbaijan 2026 — Keytruda, Opdivo, Yervoy

For unresectable Stage III and Stage IV melanoma, Pharmacy Remedy supplies the full first-line arsenal: PD-1 monotherapy (Keytruda, Opdivo), the Opdivo+Yervoy combination for high-risk disease, and BRAF/MEK targeted therapy (Tafinlar+Mekinist, Braftovi+Mektovi) for BRAF V600E/K mutant patients.

First-line treatment drugs

Other conditions